Fisiologia retinal i ceguesa hereditària

retina i ceguesa

We focus our research on the first step of vision.  We study the biochemical mechanisms that underlie the light response in photoreceptor cells of the retina; and the light-adaptation mechanisms that allow our visual system to operate in the widely varying illumination of the natural world.  We work on deciphering how gene defects in these processes lead to different forms of inherited blindness.  Our goal is to develop novel therapeutic strategies for inherited retinal disorders (IRDs) that affect 1 in 3.000 individuals and are still an unmet medical need.  We combine mouse genetic techniques [DNA editing by CRISPR/Cas9 to generate stable lines; in vivo DNA electroporation after subretinal injection to generate transient transgenics] with rigorous histological, biochemical and electrophysiological analysis, in both fundamental research and translational studies.  We assess visual function in mice by electroretinography, a means of recording the light responses of rods and cones.  For more focused protein studies, enzymatic assays, or analytical determinations by LC-MS, we also use bovine retina preparations or recombinant proteins. 

  • Ana Méndez Zunzunegui, Professora Agregada contractada  IP i Responsable del grup  mendezzu@ub.edu

 

 

 

 

 

 

  • A comprehensive study of the phosphoproteome of the retina under dark- or light- conditions, to unveil rapid light-adaptive changes in retinal metabolism, neurotransmission, membrane trafficking and other fundamental processes in neuronal physiology.
  • Characterizing the main metabolic pathways in photoreceptor cells, their dark/light adaptation and relevance for cell survival.
  • The mechanism that underlies the ciliary trafficking of retinal guanylate cyclase (RetGC) in photoreceptor cells, and its sequential association with RD3 or with Guanylate Cyclase Activating Proteins (GCAPs) in a central protein complex that is absolutely essential for the light response.
  • The mechanism of physiopathology in adRP10 and related “cGMP-disorders” and the development of novel therapeutic strategies, by characterizing the recently established D226N/IMPDH1 mouse model of adRP10, and attempting its phenotypic rescue by pharmacological and genetic means.

  • Adaptación de la retina a la luz e identificación de dianas terapéuticas para las cegueras hereditarias: IMPDH1 y metabolismo energético [RET-PAN-TARGET] REFERENCE: PID2020-115431RB-100  FUNDED BY:  RETOS MINECO (Ministerio de Economía y Competitividad)

FROM: 1/09/2021   TO: 31/08/2024       PI: Ana Méndez Zunzunegui

 

  • Nuevos medicamentos basados en ácidos nucleicos para tratar las distrofias de retina asociadas a mutaciones en PDE6A, PDE6B, PDE6G, AIPL1 y IMPDH1. [NEW-RET-THER]. FUNDED BY:  FUNDALUCE (Fundación de Lucha contra la ceguera)

FROM: 1/06/2023   TO: 31/05/2025   PI: Ana Méndez Zunzunegui

 

  • Desarrollo de MP-004 como tratamiento innovador para la Retinosis Pigmentaria y otras enfermedades oculares: estudio de eficacia y toxicología, validación del mecanismo de acción y plan de desarrollo de actividades reglamentarias preclínicas y clínicas. FUNDED BY:  COLABORACION PUBLICO-PRIVADA (Ministerio de Ciencia e Innovación, MICINN)

FROM: 1/01/2024   TO: 31/12/2026   UB  [PI: Ana Méndez Zunzunegui]
 [Consortium led by MIRAMOON PHARMA]

 

 

  • Plana-Bonamaisó A, López-Begines S, Fernández-Justel D, Junza A, Soler-Tapia A, Andilla J, Loza-Alvarez P, Rosa JL, Miralles E, Casals I, Yanes O, de la Villa P, Buey RM, Méndez A. Post-translational regulation of retinal IMPDH1 in vivo to adjust GTP synthesis to illumination conditions.  Elife. 2020 Apr7;9:e56418  doi: 10.7554/eLife.56418 PMID: 32254022. Q1  

 

  • Plana-Bonamaisó A, López-Begines S, Andilla J, Fidalgo MJ, Loza-Alvarez P, Estanyol JM, Villa P, Méndez AGCAP neuronal calcium sensor proteins mediate photoreceptor cell death in the rd3 mouse model of LCA12 congenital blindness by involving endoplasmic reticulum stress. Cell Death Dis. 2020 Jan 24;11(1):62. doi: 10.1038/s41419-020-2255-0. Q1  
  • López-Begines S, Plana-Bonamaisó, A, Méndez A.  Molecular determinants of Guanylate Cyclase Activating Protein subcellular distribution in photoreceptor cells of the retina.  Sci Rep 2018  doi:10.1038/s41598-018-20893-1.  Q1  
  • López-del Hoyo, N, López-Begines, S., Rosa, J.L., Chen, J., Méndez, A.  Functional EF-Hands in neuronal calcium sensor GCAP2 determine its phosphorylation state and subcellular distribution in vivo, and are essential for photoreceptor cell integrity. PLoS Genetics 2014: 10(7):e1004480 (19 pages)  doi: 10.1371/journal.pgen.1004480. eCollection 2014.  Q1

 

The group is seeking students that are obtaining their Master´s degree in the biomedical sciences, that are elegible for applying for a PhD fellowship to national (FPU) and regional (FI, UB) programs.

The selected candidate would be incorporated to the study of novel therapeutic developments for the treatment of selected inherited retinal dystrophies, like retinitis pigmentosa type 10 and related cGMP disorders.  Specifically, he/she would focus on: (i) contributing to the characterization of the adRP10 murine model D226N/IMPDH1; (ii) establishment of novel murine models to further characterize this disease; (iii) studying IMPDH1 protein organization into cytoophidia in vivo: composition and role of the aggregates, by doing immunoprecipitation assays and LC-MS/MS; and immunolocalization and proximity ligation assays on retinal sections; (iv) contributing to the development and testing of novel therapeutic strategies for this disease: in vitro enzymatic assays, in vivo preclinical assays, electroretinography on mice.

Candidates must have a competitive academical record (minimun of 8 over 10), and have obtained or be in the process of obtaining a Master´s degree on one of the biomedical sciences: biology; biochemistry; pharmacy; biotechnology; biomedical sciences.  Previous knowledge on bioinformatics and the handling of animals in research will be positively considered.
Granting of a PhD fellowship will grant a 4-year period predoctoral contract with the University of Barcelona to work on a PhD tesis in the IRD field under the supervision of Ana Méndez.  The graduate student will enroll at the Ph.D. Program in Biomedicine of the University of Barcelona, within the LERU (League of European Research Universities) that offers multiple formative activities: research seminars, training in experimental skills, an annual PhD day, formation in research management, open science, responsible research, and management of research career and gender issues. These are the complementary and soft skills promoted by EU guidelines to boost employability and potentiate bidirectional transfer between academia and industry. Our laboratory belongs to 1) the University of Barcelona; 2) the Bellvitge Institute for Biomedical Research (IDIBELL), certified as a health research institute by the ISCIII; and 3) the Institute of Neuroscience (UB), with the Ramiro de Maeztu award. 

The student will benefit from the infrastructure/seminar series/training programs/PhD days of these three institutions.

 

 

  • Dr. Eduard Sabidó, Center for Genomic Regulation, CRG, Barcelona
  • Dr. Pedro de la Villa, University of Alcalá de Henares, UAH
  • Dr. Javier Ruiz Ederra, University of the Vasc Country, UPV
  • Dr. Ainara Vallejo, University of the Vasc Country, UPV
  • Dr. Rubén Martínez Buey, University of Salamanca, USAL
  • Dr. Isabel Almudí, University of Barcelona, UB
  • Dr. Pablo Loza Alvarez, Institute of Photonic Sciences, ICFO
  • Dr. Pablo García Rovés, University of Barcelona, UB
  • Dr. Jose Carlos Perales, University of Barcelona, UB
  • Dr. Andrés Méndez Lucas, University of Barcelona, UB

Comparteix-ho: